VIGIL NEUROSCIENCE, INC. Proceeds from Stock Options Exercised
VIGIL NEUROSCIENCE, INC. reported Proceeds from Stock Options Exercised of $273.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2025-08-05
- VIGIL NEUROSCIENCE, INC. proceeds from stock options exercised for the quarter ending 2024-12-31 was $78.00K, a 47.17% increase year-over-year.
- VIGIL NEUROSCIENCE, INC. proceeds from stock options exercised for the quarter ending 2024-09-30 was $51.00K, a 7.27% decline year-over-year.
- VIGIL NEUROSCIENCE, INC. proceeds from stock options exercised for the quarter ending 2023-12-31 was $53.00K, a 57.26% decline year-over-year.
- VIGIL NEUROSCIENCE, INC. proceeds from stock options exercised for the quarter ending 2023-09-30 was $55.00K, a 189.47% increase year-over-year.
- VIGIL NEUROSCIENCE, INC. proceeds from stock options exercised for fiscal 2024 was $138.00K, a 84.85% decline from fiscal 2023.
- VIGIL NEUROSCIENCE, INC. proceeds from stock options exercised for fiscal 2023 was $911.00K, a 491.56% increase from fiscal 2022.
- VIGIL NEUROSCIENCE, INC. proceeds from stock options exercised for fiscal 2022 was $154.00K, a 305.26% increase from fiscal 2021.
- VIGIL NEUROSCIENCE, INC. proceeds from stock options exercised for fiscal 2021 was $38.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2025-06-30 | $273.00K 10-Q · filed 2025-08-05 | |||
| 2024-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $129.00K derived: sum of 2 quarters · filed 2025-03-13 | $138.00K 10-K · filed 2025-03-13 | |
| 2024-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $60.00K 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | $9.00K 10-Q · filed 2025-08-05 | |||
| 2023-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $108.00K derived: sum of 2 quarters · filed 2025-03-13 | $697.00K derived: sum of 3 quarters · filed 2025-03-13 | $911.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $644.00K derived: sum of 2 quarters · filed 2024-11-07 | $858.00K 10-Q · filed 2024-11-07 | $982.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $589.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $803.00K 10-Q · filed 2024-08-13 | $927.00K derived: sum of 3 quarters · filed 2024-08-13 | $946.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $214.00K 10-Q · filed 2024-05-07 | $338.00K derived: sum of 2 quarters · filed 2024-05-07 | $357.00K derived: sum of 3 quarters · filed 2024-05-07 | $359.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $143.00K derived: sum of 2 quarters · filed 2024-03-26 | $145.00K derived: sum of 3 quarters · filed 2024-03-26 | $154.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $21.00K derived: sum of 2 quarters · filed 2023-11-07 | $30.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $11.00K 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $9.00K 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $38.00K 10-K · filed 2023-03-21 |